HPV-vaccination against cervical carcinoma: will it really work?

scientific article published on 21 February 2007

HPV-vaccination against cervical carcinoma: will it really work? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/S00430-007-0039-0
P698PubMed publication ID17318575

P2093author name stringGerd Gross
P2860cites workWorldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisQ46926059
Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial NeoplasiaQ60441062
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regionsQ24599668
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialQ28236008
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult womenQ28271727
Epidemiologic classification of human papillomavirus types associated with cervical cancerQ29616213
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideQ29617514
Role of herd immunity in determining the effect of vaccines against sexually transmitted diseaseQ34380787
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialQ34415030
Global control of hepatitis B virus infection.Q34749752
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.Q35854601
Efficacy and other milestones for human papillomavirus vaccine introductionQ35999045
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer controlQ36065397
Improving adolescent health: focus on HPV vaccine acceptanceQ36323244
Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a reviewQ36490571
Human Papillomaviruses and Their Possible Role in Squamous Cell CarcinomasQ37711514
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancerQ40788937
Human papillomavirus-associated malignancies in HIV-positive men and womenQ40934611
Papillomavirus-like particles and HPV vaccine developmentQ41585272
A controlled trial of a human papillomavirus type 16 vaccineQ44366335
Women's desired information about human papillomavirusQ45292274
Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problemsQ45422657
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialQ45552005
The theoretical population-level impact of a prophylactic human papilloma virus vaccineQ45730281
P433issue3
P304page(s)121-125
P577publication date2007-02-21
P1433published inMedical Microbiology and ImmunologyQ15760239
P1476titleHPV-vaccination against cervical carcinoma: will it really work?
P478volume196

Reverse relations

cites work (P2860)
Q36478517Attitude and knowledge of Iranian female nurses about human papilomavirus infection and cervical cancer: a cross sectional survey
Q33344903Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Q42193505Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.
Q34973338Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania
Q38234231Vaccination against infectious diseases: what is promising?
Q95788212[Impact of prophylactic HPV vaccines on dermatology and venereology]

Search more.